4.6 Article

Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study

Related references

Note: Only part of the references are listed.
Review Oncology

Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer

Brittany N. Hughes et al.

Summary: This study characterizes the global landscape of publication and reference to BRCA1/2 genetic testing guidelines, revealing geographic disparities with a large emphasis on North American and European guidelines in the published literature. This highlights the need for uniform guidelines to improve global health equity.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India

Divya Pillai et al.

Summary: The incidence of breast cancer in India is increasing, and there is low awareness of the disease and its risk factors. An interdisciplinary team has developed affordable and easy-to-understand transmedia tools to communicate breast cancer risk. The preferred communication methods include storytelling techniques such as animations and infographics.

CANCERS (2023)

Article Oncology

Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial

Susana Banerjee et al.

Summary: The study demonstrated that maintenance therapy with olaparib for 2 years can extend progression-free survival to over 4.5 years in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation. These results support the use of maintenance olaparib as a standard of care in this setting.

LANCET ONCOLOGY (2021)

Review Oncology

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

Pascal Pujol et al.

Summary: BRCA1 and BRCA2 gene pathogenic variants play a crucial role in hereditary breast cancer, and updated comprehensive practice guidelines are needed for BRCA genotyping. Integrative recommendations for genetic counselling and personalized management of early and metastatic breast cancer can help clinicians optimize BRCA testing practices and standardize outcomes.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

Dhivya Chandrasekaran et al.

Summary: Multigene testing in ovarian cancer, especially after counselling by multidisciplinary clinical teams, shows a high uptake rate of 97% and identifies a significant proportion of patients with pathogenic variants such as BRCA1/BRCA2, RAD51C/RAD51D/BRIP1. Prospective parallel somatic and germline panel testing is recommended to maximize variant identification in cancer patients.

CANCERS (2021)

Review Oncology

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

Sudha Sundar et al.

Summary: The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group to identify optimal pathways for BRCA germline and tumor testing in ovarian cancer patients. The group explored models of consent, quality standards at pathology laboratories, and experience from cancer centers to make recommendations for implementation.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

Editorial Material Oncology

Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations

Kathleen N. Moore et al.

GYNECOLOGIC ONCOLOGY (2020)

Article Oncology

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline

Panagiotis A. Konstantinopoulos et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Health Care Sciences & Services

Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist

Karen R. Sepucha et al.

BMJ QUALITY & SAFETY (2018)

Article Medicine, General & Internal

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

K. Moore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Oncology

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer

Christopher P. Childers et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

Review Medical Informatics

A systematic development process for patient decision aids

Angela Coulter et al.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2013)

Article Multidisciplinary Sciences

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Tom Walsh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Endocrinology & Metabolism

Genetic susceptibility to breast cancer

Angela R. Bradbury et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2007)